Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KARLSLUNDE FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.0% 6.2% 4.3% 5.4% 5.0% 6.3% 18.6% 18.4%   Credit score (0-100)   45 38 46 41 43 38 7 8   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   811 777 954 798 838 762 0.0 0.0   EBITDA   199 190 299 190 351 119 0.0 0.0   EBIT   199 190 299 190 351 119 0.0 0.0   Pre-tax profit (PTP)   210.3 -8.5 333.9 114.6 318.5 89.8 0.0 0.0   Net earnings   210.3 -8.5 333.9 114.6 318.5 89.8 0.0 0.0   Pre-tax profit without non-rec. items   210 -8.5 334 115 319 89.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   514 506 839 954 1,273 1,362 0.0 0.0   Interest-bearing liabilities   277 229 212 205 7.6 7.6 0.0 0.0   Balance sheet total (assets)   856 860 1,211 1,211 1,307 1,392 0.0 0.0   Net Debt   -23.6 134 73.7 104 -41.6 -30.3 0.0 0.0     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   811 777 954 798 838 762 0.0 0.0   Gross profit growth   2.8% -4.2% 22.9% -16.4% 5.0% -9.1% -100.0% 0.0%   Employees   1 0 0 0 0 0 0 0   Employee growth %   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 -586.9 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   856 860 1,211 1,211 1,307 1,392 0 0   Balance sheet change%   33.0% 0.4% 40.8% 0.0% 7.9% 6.5% -100.0% 0.0%   Added value   198.8 776.7 298.9 190.3 351.2 119.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.5% 24.4% 31.3% 23.9% 41.9% 15.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   31.4% 25.9% 32.4% 15.7% 27.9% 8.9% 0.0% 0.0%   ROI %   34.3% 29.2% 37.5% 17.2% 28.8% 9.0% 0.0% 0.0%   ROE %   51.4% -1.7% 49.7% 12.8% 28.6% 6.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   60.0% 58.8% 69.3% 78.8% 97.4% 97.9% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -11.9% 70.6% 24.7% 54.7% -11.8% -25.4% 0.0% 0.0%   Gearing %   53.8% 45.3% 25.3% 21.5% 0.6% 0.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.1% 91.3% 0.6% 36.3% 30.7% 388.3% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   2.4 2.3 3.1 4.5 37.2 45.5 0.0 0.0   Current Ratio   2.4 2.3 3.1 4.5 37.2 45.5 0.0 0.0   Cash and cash equivalent   300.2 95.1 138.6 101.3 49.3 37.9 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   173.6 373.1 670.6 809.2 1,187.6 1,306.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   199 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   199 0 0 0 0 0 0 0   EBIT / employee   199 0 0 0 0 0 0 0   Net earnings / employee   210 0 0 0 0 0 0 0